Persistent effects of in utero overnutrition on offspring adiposity: the Exploring Perinatal Outcomes among Children (EPOCH) study.
Adipose Tissue
/ pathology
Adiposity
Adolescent
Body Mass Index
Child
Colorado
/ epidemiology
Diabetes, Gestational
/ physiopathology
Female
Humans
Linear Models
Longitudinal Studies
Magnetic Resonance Imaging
Male
Mothers
Obesity
/ complications
Overnutrition
/ complications
Pregnancy
Prenatal Exposure Delayed Effects
Prospective Studies
Risk Factors
Treatment Outcome
Fetal programming
GDM
Maternal diabetes
Obesity
Puberty
SAT
VAT
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
01
05
2019
accepted:
19
07
2019
pubmed:
25
8
2019
medline:
10
7
2020
entrez:
25
8
2019
Statut:
ppublish
Résumé
We previously showed that intrauterine exposure to gestational diabetes mellitus (GDM) increases selected markers of adiposity in pre-pubertal adolescents. In the present study, we examined these associations in adolescence, and explored whether they are strengthened as the participants transition through puberty. Data from 597 individuals (505 unexposed, 92 exposed) participating in the longitudinal Exploring Perinatal Outcomes among Children (EPOCH) study in Colorado were collected at two research visits when the participants were, on average, 10.4 and 16.7 years old. Adiposity measures included BMI, waist/height ratio, and visceral and subcutaneous adipose tissue (as determined by MRI). Separate general linear mixed models were used to assess the longitudinal relationships between exposure to maternal GDM and each adiposity outcome. We tested whether the effect changed over time by including an interaction term between exposure and age in our models, and whether the associations were explained by postnatal behaviours. Compared with unexposed participants, those exposed to maternal GDM had higher BMI (β = 1.28; 95% CI 0.35, 2.21; p < 0.007), waist/height ratio (β = 0.03; 95% CI 0.01, 0.04; p = 0.0004), visceral adipose tissue (β = 4.81; 95% CI 1.08, 8.54; p = 0.01) and subcutaneous adipose tissue (β = 35.15; 95% CI 12.43, 57.87; p < 0.003). The magnitude of these differences did not change over time and the associations did not appear to be explained by postnatal behaviours. Our data provide further evidence that intrauterine exposure to maternal GDM is associated with increased offspring adiposity, an effect that appears early in life and tracks throughout adolescence. Efforts to prevent childhood obesity following intrauterine exposure to maternal GDM should target the prenatal or early life periods.
Identifiants
pubmed: 31444527
doi: 10.1007/s00125-019-04981-z
pii: 10.1007/s00125-019-04981-z
pmc: PMC7593989
mid: NIHMS1630981
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2017-2024Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK048520
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK068001
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM121081
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM111901
Pays : United States
Références
Diabet Med. 2017 Dec;34(12):1696-1700
pubmed: 29048747
Diabetologia. 2010 Jan;53(1):89-97
pubmed: 19841891
Diabetologia. 2011 Jan;54(1):87-92
pubmed: 20953862
Circulation. 2011 Jan 25;123(3):258-65
pubmed: 21220735
Diabetes. 1980 Dec;29(12):1023-35
pubmed: 7002669
Diabetes. 2000 Dec;49(12):2208-11
pubmed: 11118027
Int J Obes (Lond). 2008 Aug;32 Suppl 3:S56-9
pubmed: 18695655
Diabetes Care. 2015 Jan;38 Suppl:S8-S16
pubmed: 25537714
Paediatr Perinat Epidemiol. 2010 Sep;24(5):441-8
pubmed: 20670225
Biometrics. 1997 Sep;53(3):983-97
pubmed: 9333350
JAMA. 2018 Sep 11;320(10):1005-1016
pubmed: 30208453
N Engl J Med. 1983 Feb 3;308(5):242-5
pubmed: 6848933
Pediatrics. 2003 Mar;111(3):e221-6
pubmed: 12612275
Annu Rev Med. 1968;19:283-300
pubmed: 4297619
Pediatrics. 1998 Feb;101(2):E9
pubmed: 9445519
Diabetes Care. 2007 Jul;30 Suppl 2:S169-74
pubmed: 17596467
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
N Engl J Med. 2014 Jan 30;370(5):403-11
pubmed: 24476431
J Am Diet Assoc. 2008 May;108(5):862-6
pubmed: 18442512
Diabetologia. 2019 Oct;62(10):1779-1788
pubmed: 31451868
J Pediatr. 2014 Apr;164(4):807-10
pubmed: 24388326
Am J Hypertens. 2009 Feb;22(2):215-20
pubmed: 19023272
N Engl J Med. 2004 Jun 3;350(23):2362-74
pubmed: 15175438
Int J Obes Relat Metab Disord. 2000 Dec;24(12):1653-9
pubmed: 11126220
J Clin Endocrinol Metab. 2009 Jul;94(7):2464-70
pubmed: 19417040
Pediatr Obes. 2019 Dec;14(12):e12562
pubmed: 31274243
Int J Obes (Lond). 2013 Jul;37(7):943-6
pubmed: 23478429
Diabetologia. 2015 May;58(5):937-41
pubmed: 25628236
Int J Obes (Lond). 2006 Jan;30(1):23-30
pubmed: 16344845
Obesity (Silver Spring). 2018 Sep;26(9):1457-1466
pubmed: 30226003
Diabetes. 1979 Dec;28(12):1039-57
pubmed: 510803
Diabetologia. 2019 Apr;62(4):598-610
pubmed: 30648193
N Engl J Med. 2002 Mar 14;346(11):802-10
pubmed: 11893791
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581